Istvan Petak’s overview of AI in cancer research at the Budapest IT Fest
Istvan Petak shared on LinkedIn:
“Hello Budapest, Hello IT Fest// Business Fest. Computational technologies and artificial intelligence have so much potential in healthcare, particularly in our fight against cancer. AI can improve diagnostics during endoscopy, radiology, and histology, help us discover new drug targets, develop new therapies, and improve personalized treatment decisions. I was honored to give an overview of AI in cancer research at the Budapest IT Fest. IT companies and innovative start-ups play a pivotal role in developing the next generation of healthcare solutions leveraging the advancement of computer and data sciences. Thank you, Monika Weber, for the many excellent photos I could choose from.”
Source: Istvan Petak/LinkedIn
Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023